Journal List > Lab Anim Res > v.26(1) > 1053656

Park, Nam, Kwon, and Suh: New Splicing Variants of the Murine Damaged DNA Binding 2

Abstract

Damaged DNA binding (DDB) protein is an important gene in the repair of damaged DNA. DDB is a heterodimer (DDB1 and DDB2) protein, murine DDB2 has 10 exons about 1.5kb in size (Genbank Accession No. AY027937). Here we identified five DDB2 variants (M1-M5) from various mouse tissues that are generated by alternative splicing. We used reverse transcription-PCR (RT-PCR) to identify splicing variants and isolated PCR products using an agarose-gel PCR purification kit. All isolated PCR products were cloned and the structure of splicing variants was confirmed by sequencing. The first splicing variant M1 was generated by omission of exon 4. The second splicing variant M2, by omission of exons 4-5. The third variants M3 was generated by omission from the middle of exon 1 to exon 6 and was expressed in the heart. Fourth variants M4 was generated by omission of exon 2 and exons 4-7. M5, the last splicing variant was generated by omission of exons 4-7. M4 and M5 were expressed in the spleen. Analysis of tissue distribution by RT-PCR indicates that M1 is most highly expressed in the mouse brain. These results indicated that murine DDB2 has five splicing variants and splicing variants expression patterns were different depending on mouse tissue. Further functional studies of each splicing variants will provide more information about the molecular mechanism of DDB2 function and DDB2 gene expression regulation.

REFERENCES

Aboussekhra A.., Biggerstaff M.., Shivji M.K.., Vilpo J.A.., Moncollin V.., Podust V.N.., Protic M.., Hubscher U.., Egly J.M.., Wood R.D.1995. Mammalian DNA nucleotide excision repair reconstituted with purified protein components. Cell. 80(6):859–868.
crossref
Black D.L.2003. Mechanisms of alternative pre-messenger RNA splicing. Annu. Rev. Biochem. 72:291–336.
crossref
Bohr V.A.., Smith C.A.., Okumoto D.S.., Hanawalt P.C.1985. DNA repair in an active gene: removal of pyrimidine dimers from the DHFR gene of CHO cells is much more efficient than in the genome overall. Cell. 40(2):359–369.
crossref
David C.J.., Manley J.L.2008. The search for alternative splicing regulators: new approaches offer a path to a splicing code. Genes Dev. 22(3):279–285.
crossref
Fedor M.J.2008. Alternative splicing minireview series: combinatorial control facilitates splicing regulation of gene expression and enhances genome diversity. J. Biol. Chem. 283(3):1209–1210.
crossref
Fujiwara Y.., Masutani C.., Mizukoshi T.., Kondo J.., Hanaoka F.., Iwai S.1999. Characterization of DNA recognition by the human UV-damaged DNA-binding protein. J. Biol. Chem. 274(28):20027–20033.
crossref
Graveley B.R.2001. Alternative splicing: increasing diversity in the proteomic world. Trends Genet. 17(2):100–107.
crossref
Graveley B.R.2009. Alternative splicing: regulation without regulators. Nat. Struct. Mol. Biol. 16(1):13–15.
crossref
Hwang B.J.., Ford J.M.., Hanawalt P.C.., Chu G.1999. Expression of the p48 xeroderma pigmentosum gene is p53-dependent and is involved in global genomic repair. Proc. Natl. Acad. Sci. USA. 96(2):424–428.
crossref
Inoki T.., Yamagami S.., Inoki Y.., Tsuru T.., Hamamoto T.., Kagawa Y.., Mori T.., Endo H.2004. Human DDB2 splicing variants are dominant negative inhibitors of UV-damaged DNA repair. Biochem. Biophys. Res. Commun. 314(4):1036–1043.
crossref
Itoh M.., Nagatomo K.., Kubo Y.., Saitoh O.2006. Alternative splicing of RGS8 gene changes the binding property to the M1 muscarinic receptor to confer receptor type-specific Gq regulation. J. Neurochem. 99(6):1505–1516.
crossref
Itoh T.., Cado D.., Kamide R.., Linn S.2004. DDB2 gene disruption leads to skin tumors and resistance to apoptosis after exposure to ultraviolet light but not a chemical carcinogen. Proc. Natl. Acad. Sci. USA. 101(7):2052–2057.
crossref
Itoh T.., Mori T.., Ohkubo H.., Yamaizumi M.1999. A newly identified patient with clinical xeroderma pigmentosum phenotype has a non-sense mutation in the DDB2 gene and incomplete repair in (6-4) photoproducts. J. Invest. Dermatol. 113(2):251–257.
crossref
Keeney S.., Chang G.J.., Linn S.1993. Characterization of a human DNA damage binding protein implicated in xeroderma pigmentosum E. J. Biol. Chem. 268(28):21293–21300.
crossref
Mayeda A.., Helfman D.M.., Krainer A.R.1993. Modulation of exon skipping and inclusion by heterogeneous nuclear ribonucleoprotein A1 and pre-mRNA splicing factor SF2/ASF. Mol. Cell Biol. 13(5):2993–3001.
crossref
Ohno G.., Hagiwara M.., Kuroyanagi H.2008. STAR family RNA-binding protein ASD-2 regulates developmental switching of mutually exclusive alternative splicing in vivo. Genes Dev. 22(3):360–374.
crossref
Roesser J.R.., Liittschwager K.., Leff S.E.1993. Regulation of tissue-specific splicing of the calcitonin/calcitonin gene-related peptide gene by RNA-binding proteins. J. Biol. Chem. 268(11):8366–8375.
crossref
Stoyanova T.., Roy N.., Kopanja D.., Raychaudhuri P.., Bagchi S.2009. DDB2 (Damaged-DNA binding protein 2) in nucleotide excision repair and DNA damage response. Cell Cycle. 8(24):4067–4071.
crossref

Figure 1.
Mouse DDB2 genomic structure. Exons 1 to 10 are shown as black boxes. The numbers in the black boxes represent exon numbers and the above numbers are nucleotide numbers. Arrows indicated primers.
lar-26-91f1.tif
Figure 2.
Mouse DDB2 expression and splicing variants in various mouse tissues. (A) DDB2 wild type (WT) distribution in various tissues by reverse-transcriptase PCR (RT-PCR). (B) DDB2 splicing variants (M1 and M2) in various tissues (C) Amplification of DDB2 splicing variants (M3, M4 and M5) cloned in TOPO vector in the heart and spleen. β-actin was used as an internal control for the PCR.
lar-26-91f2.tif
Figure 3.
DDB2 wild type and variants gene structure. The structure of splicing variants was confirmed by sequencing. M1, omission of exon 4; M2, omission exons 4-5; M3, omission from the middle of exon 1 to exon 6; M4, omission of exon 2 and exons 4-7; M5, omission of exons 4-7.
lar-26-91f3.tif
TOOLS
Similar articles